BDNF Pregnancy Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the correlation between varying levels of neuropeptides and birth outcomes. Neuropeptides are substances (proteins) produced in the body in very small amounts but without which the nervous system cannot function properly, and which might have a role in the health of a newborn. As part of this study, we are collecting blood samples from pregnant women.

Neuropeptides and hormones can be measured in blood. This study will involve three blood draws from the participants arm. Demographic information will also be requested, and participants will be asked to complete questionnaires about their mood and personal experiences at each visit.

Our hypothesis is that participants with lower levels of brain-derived neurotrophic factor (BDNF) will be at increased risk for poor birth outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Plasma Brain Natriuretic Peptide Levels in Pregnancy

NCT00324402

Cardiomyopathy Pregnancy

COMPLETED

COVID-19 Infection and Fetal-neonatal Outcomes

NCT04699578

Covid19 Obstetric Complication SARS-CoV Infection +3 more

UNKNOWN

Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure

NCT04540029

Prenatal Stress

COMPLETED

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

NCT06220721

Hypertension, Pregnancy-Induced

RECRUITING NA

Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models

NCT02709174

Pulmonary Embolism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective, non-randomized trial will evaluate peripheral serum blood levels of BDNF in participants recruited from previously identified University of Pennsylvania obstetrics and gynecological (OB/GYN) clinics. A total of 100 pregnant subjects will be recruited consecutively and evaluated in the first and third trimester of their pregnancy as well as within a month after delivery.

The entire project will take one year.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Pregnant Women

Participants 8 to 12 weeks gestational age as determined by their physician.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must be at least 18 years old and being treated at an outpatient OB/GYN clinic;
* At least 8 weeks pregnant;
* Capable of giving informed consent.

Exclusion Criteria

* Participants younger than 18 years of age;
* History of preterm birth;
* Psychiatric medications during current pregnancy;
* Participants with a history of hematologic disorders;
* Participants who refuse informed consent.

Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes